Milestone Scientific Inc.

Milestone Scientific Inc. is a biomedical technology research and development company focused on developing and commercializing proprietary computer-controlled drug delivery systems for both medical and dental applications. The company's core mission is to advance the science of these systems to provide significant efficiency and enhanced patient comfort and safety during injections and fluid aspiration procedures. Milestone Scientific is headquartered in Roseland, New Jersey.

The company's key technological platform is Dynamic Pressure Sensing (DPS) Technology, which enables real-time control of flow rate and measurement of pressure at the needle tip. In the dental market, Milestone Scientific offers products such as The Wand®, marketed under the CompuDent® and STA Single Tooth Anesthesia System® brands, designed for local anesthesia delivery. For medical applications, its product portfolio includes the CompuFlo® Epidural Computer Controlled Anesthesia System, which has FDA clearance for epidural procedures, and CompuMed® for various medical procedures including plastic surgery, podiatry, and orthopedics.

Recent developments include the appointment of Eric C. Hines as Chief Executive Officer in August 2025 and the transition of Benedetta I. Casamento to Executive Chair in June 2026, alongside the addition of new independent board members. Financially, Milestone Scientific reported Q1 2026 revenue of $2.16 million, with its medical segment revenue more than doubling year-over-year. The company completed a $2.15 million private placement in April 2026 and projects 2026 revenue between $9.8 million and $10.2 million, anticipating double-digit growth and significant expansion in CompuFlo sales. Milestone Scientific aims to achieve cash flow breakeven in early 2027.